Pharmerging Market 2027 by Product | The Insight Partners

Pharmerging Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Product (Pharmaceutical, Other healthcare verticals)

Report Code: TIPRE00008498 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Pharmerging plays a rapid rise in the pharmaceutical industry. It comes under various pharmaceutical products that are used to treat multiple diseases. The increasing prevalence of non-communicable diseases and an increase in life expectancy has been supporting the pharmerging market.

MARKET DYNAMICS

The pharmerging market is anticipated to grow due to the rising prevalence of non-transmissible illnesses, aging population, increasing life expectancy, surging government expenditure on health care, and constant research & development. However, IP protection issues and socio-political issues in cross geography transactions and stringent price control lead to value erosion and restrain the market growth. Moreover, growth opportunities in emerging markets and a positive outlook towards the adoption of targeted therapies will drive the market growth in future.

MARKET SCOPE

The "Pharmerging Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in pharmerging market with detailed market segmentation by product and geography. The pharmerging market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in pharmerging market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The pharmerging market is segmented on the basis of product. Based on product the market is segmented as pharmaceutical and other healthcare verticals. Further, on the basis of pharmaceutical the market is categorized as patented prescription drugs, generic prescription drug and OTC drugs. Further, on the basis of other healthcare verticals the market is categorized as medical device, clinical diagnostics and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in pharmerging market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pharmerging market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pharmerging market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pharmerging market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in pharmerging market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in pharmerging market are anticipated to have lucrative growth opportunities in the future with the rising demand for in pharmerging market in the global market. Below mentioned is the list of few companies engaged in the pharmerging market.

The report also includes the profiles of key in pharmerging market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- AstraZeneca
- F.Hoffmann-La Roche
- Johnson & Johnson
- Koninklijke Philips N.V.
- LUPIN
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc
- Sanofi
- Sun Pharmaceutical Industries Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmerging Market - By Product
1.3.2 Pharmerging Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PHARMERGING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PHARMERGING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PHARMERGING MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMERGING - GLOBAL MARKET OVERVIEW
6.2. PHARMERGING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PHARMERGING MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PHARMACEUTICAL
7.3.1. Overview
7.3.2. Pharmaceutical Market Forecast and Analysis
7.3.3. Patented prescription drugs Market
7.3.3.1. Overview
7.3.3.2. Patented prescription drugs Market Forecast and Analysis
7.3.4. Generic prescription drug Market
7.3.4.1. Overview
7.3.4.2. Generic prescription drug Market Forecast and Analysis
7.3.5. OTC drugs Market
7.3.5.1. Overview
7.3.5.2. OTC drugs Market Forecast and Analysis
7.4. OTHER HEALTHCARE VERTICALS
7.4.1. Overview
7.4.2. Other healthcare verticals Market Forecast and Analysis
7.4.3. Medical device Market
7.4.3.1. Overview
7.4.3.2. Medical device Market Forecast and Analysis
7.4.4. Clinical diagnostics Market
7.4.4.1. Overview
7.4.4.2. Clinical diagnostics Market Forecast and Analysis
7.4.5. Other Market
7.4.5.1. Overview
7.4.5.2. Other Market Forecast and Analysis
8. PHARMERGING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Pharmerging Market Overview
8.1.2 North America Pharmerging Market Forecasts and Analysis
8.1.3 North America Pharmerging Market Forecasts and Analysis - By Product
8.1.4 North America Pharmerging Market Forecasts and Analysis - By Countries
8.1.4.1 United States Pharmerging Market
8.1.4.1.1 United States Pharmerging Market by Product
8.1.4.2 Canada Pharmerging Market
8.1.4.2.1 Canada Pharmerging Market by Product
8.1.4.3 Mexico Pharmerging Market
8.1.4.3.1 Mexico Pharmerging Market by Product
8.2. EUROPE
8.2.1 Europe Pharmerging Market Overview
8.2.2 Europe Pharmerging Market Forecasts and Analysis
8.2.3 Europe Pharmerging Market Forecasts and Analysis - By Product
8.2.4 Europe Pharmerging Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Pharmerging Market
8.2.4.1.1 Germany Pharmerging Market by Product
8.2.4.2 France Pharmerging Market
8.2.4.2.1 France Pharmerging Market by Product
8.2.4.3 Italy Pharmerging Market
8.2.4.3.1 Italy Pharmerging Market by Product
8.2.4.4 Spain Pharmerging Market
8.2.4.4.1 Spain Pharmerging Market by Product
8.2.4.5 United Kingdom Pharmerging Market
8.2.4.5.1 United Kingdom Pharmerging Market by Product
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Pharmerging Market Overview
8.3.2 Asia-Pacific Pharmerging Market Forecasts and Analysis
8.3.3 Asia-Pacific Pharmerging Market Forecasts and Analysis - By Product
8.3.4 Asia-Pacific Pharmerging Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Pharmerging Market
8.3.4.1.1 Australia Pharmerging Market by Product
8.3.4.2 China Pharmerging Market
8.3.4.2.1 China Pharmerging Market by Product
8.3.4.3 India Pharmerging Market
8.3.4.3.1 India Pharmerging Market by Product
8.3.4.4 Japan Pharmerging Market
8.3.4.4.1 Japan Pharmerging Market by Product
8.3.4.5 South Korea Pharmerging Market
8.3.4.5.1 South Korea Pharmerging Market by Product
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Pharmerging Market Overview
8.4.2 Middle East and Africa Pharmerging Market Forecasts and Analysis
8.4.3 Middle East and Africa Pharmerging Market Forecasts and Analysis - By Product
8.4.4 Middle East and Africa Pharmerging Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Pharmerging Market
8.4.4.1.1 South Africa Pharmerging Market by Product
8.4.4.2 Saudi Arabia Pharmerging Market
8.4.4.2.1 Saudi Arabia Pharmerging Market by Product
8.4.4.3 U.A.E Pharmerging Market
8.4.4.3.1 U.A.E Pharmerging Market by Product
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Pharmerging Market Overview
8.5.2 South and Central America Pharmerging Market Forecasts and Analysis
8.5.3 South and Central America Pharmerging Market Forecasts and Analysis - By Product
8.5.4 South and Central America Pharmerging Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Pharmerging Market
8.5.4.1.1 Brazil Pharmerging Market by Product
8.5.4.2 Argentina Pharmerging Market
8.5.4.2.1 Argentina Pharmerging Market by Product
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. PHARMERGING MARKET, KEY COMPANY PROFILES
10.1. ASTRAZENECA
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. F.HOFFMANN-LA ROCHE
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. JOHNSON AND JOHNSON
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. KONINKLIJKE PHILIPS N.V.
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. LUPIN
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. MERCK AND CO. INC.
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. NOVARTIS AG
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. PFIZER INC
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SANOFI
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. SUN PHARMACEUTICAL INDUSTRIES LTD
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. F.Hoffmann-La Roche
3. Johnson & Johnson
4. Koninklijke Philips N.V.
5. LUPIN
6. Merck & Co. Inc.
7. Novartis AG
8. Pfizer Inc
9. Sanofi
10. Sun Pharmaceutical Industries Ltd
TIPRE00008498
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking